Want to see AU:4DX full AI Analyst Report?
Total Valuation
4DMedical Ltd has a market cap or net worth of AU$2.71B. The enterprise value is AU$2.27B.
Market CapAU$2.71B
Enterprise ValueAU$2.27B
Share Statistics
4DMedical Ltd has 597,559,140 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding597,559,140
Owned by Insiders12.23%
Owned by Institutions―
Financial Efficiency
4DMedical Ltd’s return on equity (ROE) is -0.47 and return on invested capital (ROIC) is -51.96%.
Return on Equity (ROE)-0.47
Return on Assets (ROA)-0.32
Return on Invested Capital (ROIC)-51.96%
Return on Capital Employed (ROCE)-0.63
Revenue Per Employee40.37K
Profits Per Employee-207.38K
Employee Count145
Asset Turnover0.06
Inventory Turnover0.51
Valuation Ratios
The current PE Ratio of 4DMedical Ltd is ―. 4DMedical Ltd’s PEG ratio is -0.06.
PE Ratio―
PS Ratio8.81
PB Ratio0.80
Price to Fair Value0.80
Price to FCF-1.49
Price to Operating Cash Flow-98.37
PEG Ratio-0.06
Income Statement
In the last 12 months, 4DMedical Ltd had revenue of 5.85M and earned -30.07M in profits. Earnings per share was -0.14.
Revenue5.85M
Gross Profit5.39M
Operating Income-47.50M
Pretax Income-35.36M
Net Income-30.07M
EBITDA-45.82M
Earnings Per Share (EPS)-0.14
Cash Flow
In the last 12 months, operating cash flow was -22.82M and capital expenditures -162.39K, giving a free cash flow of -22.99M billion.
Operating Cash Flow-22.82M
Free Cash Flow-22.99M
Free Cash Flow per Share-0.04
Dividends & Yields
4DMedical Ltd pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.21
52-Week Price Change1787.50%
50-Day Moving Average4.02
200-Day Moving Average3.43
Relative Strength Index (RSI)51.10
Average Volume (3m)10.77M
Important Dates
4DMedical Ltd upcoming earnings date is Aug 27, 2026, Before Open (Confirmed).
Last Earnings DateFeb 26, 2026
Next Earnings DateAug 27, 2026
Ex-Dividend Date―
Financial Position
4DMedical Ltd as a current ratio of 0.89, with Debt / Equity ratio of -22.59%
Current Ratio0.89
Quick Ratio0.84
Debt to Market Cap0.02
Net Debt to EBITDA0.06
Interest Coverage Ratio-186.22
Taxes
In the past 12 months, 4DMedical Ltd has paid -5.29M in taxes.
Income Tax-5.29M
Effective Tax Rate0.15
Enterprise Valuation
4DMedical Ltd EV to EBITDA ratio is -1.07, with an EV/FCF ratio of -1.42.
EV to Sales8.37
EV to EBITDA-1.07
EV to Free Cash Flow-1.42
EV to Operating Cash Flow-1.42
Balance Sheet
4DMedical Ltd has AU$56.76M in cash and marketable securities with AU$6.42M in debt, giving a net cash position of AU$50.35M billion.
Cash & Marketable SecuritiesAU$56.76M
Total DebtAU$6.42M
Net CashAU$50.35M
Net Cash Per ShareAU$0.08
Tangible Book Value Per Share-AU$0.01
Margins
Gross margin is -396.61%, with operating margin of -811.49%, and net profit margin of -513.72%.
Gross Margin-396.61%
Operating Margin-811.49%
Pretax Margin-604.09%
Net Profit Margin-513.72%
EBITDA Margin-782.79%
EBIT Margin-822.76%
Analyst Forecast
The average price target for 4DMedical Ltd is AU$4.97, which is 11.43% higher than the current price. The consensus rating is Hold
Price TargetAU$4.97
Price Target Upside-14.95% Downside
Analyst ConsensusHold
Analyst Count3
Revenue Growth Forecast-0.80%
EPS Growth Forecast-249.48%